Cargando…

Anti-PD-1 Immunotherapy and Bee Venom for Relapsed and Refractory Liposarcoma: A Case Report

Cancer immunotherapies, including immune checkpoint inhibitors, elicit long-term clinical responses but many cancer patients do not respond. Intensive efforts are therefore underway to identify additional immune pathways that may be modulated to enhance the efficacy of existing immunotherapies. Bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Wei, Zhang, Yeke, Yang, Gaoyi, Geng, Yanhua, Chen, Da, Wang, Jun, Ye, Yang, Wang, Huaichong, Xia, Dajing, Hu, Fuliang, Jiang, Jing, Xu, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117145/ https://www.ncbi.nlm.nih.gov/pubmed/33996596 http://dx.doi.org/10.3389/fonc.2021.668992

Ejemplares similares

Combination of omalizumab and bee venom immunotherapy: does it work?
por: Yılmaz, İnsu, et al.
Publicado: (2018)

Research trends on anti-PD-1/PD-L1 immunotherapy for esophageal cancer: A bibliometric analysis
por: Yang, Yuanyuan, et al.
Publicado: (2022)

Radiopharmaceuticals for Relapsed or Refractory Leukemias
por: Kunos, Charles A., et al.
Publicado: (2019)

Successful Treatment of Refractory and Relapsed CNS Acute Lymphoblastic Leukemia With CD-19 CAR-T Immunotherapy: A Case Report
por: Htun, Kyaw Thu, et al.
Publicado: (2021)

Simultaneous up‐dosing of bee and vespid venom immunotherapy is safe
por: Čerpes, Urban, et al.
Publicado: (2019)

Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers
por: Kunos, Charles A., et al.
Publicado: (2019)

Vincristine, Irinotecan, and Temozolomide in Patients With Relapsed/Refractory Neuroblastoma
por: Zhu, Jia, et al.
Publicado: (2022)

Bee Venom: From Venom to Drug
por: Khalil, Abdelwahab, et al.
Publicado: (2021)

Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
por: Sahiner, Umit Murat, et al.
Publicado: (2019)

Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma
por: Yang, Yu, et al.
Publicado: (2023)

Immunotherapy – 2076. A controlled study of delta inulin-adjuvanted honey bee venom immunotherapy
por: Heddle, Robert, et al.
Publicado: (2013)

Effects of Bee Venom
por: D'Abreu, A. R.
Publicado: (1926)

The Effects of Bee Venom
por: de Castro, A. Bayley
Publicado: (1927)

Treatment selection for patients with relapsed or refractory follicular lymphoma
por: Skarbnik, Alan Z., et al.
Publicado: (2023)

Preformulation Studies of Bee Venom for the Preparation of Bee Venom-Loaded PLGA Particles
por: Park, Min-Ho, et al.
Publicado: (2015)

Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
por: Lee, Boram, et al.
Publicado: (2021)

Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom
por: Stoevesandt, Johanna, et al.
Publicado: (2013)

Role of radiotherapy in treatment of extramedullary relapse following total marrow and lymphoid irradiation in high-risk and/or relapsed/refractory acute leukemia
por: Ladbury, Colton, et al.
Publicado: (2022)

Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms Tumor
por: Wang, Juan, et al.
Publicado: (2021)

A case report of perineal liposarcoma
por: Sakly, Aymen, et al.
Publicado: (2019)

The prevalence of Api m 10 sensitization and the modification of immunotherapy in bee venom allergy
por: Górska, Aleksandra, et al.
Publicado: (2021)

Component-Resolved Evaluation of the Risk and Success of Immunotherapy in Bee Venom Allergic Patients
por: Rosiek-Biegus, Marta, et al.
Publicado: (2022)

Case report: Two cases of primary paratesticular liposarcoma
por: Li, Jiaxing, et al.
Publicado: (2022)

Cytopenia after chimeric antigen receptor T cell immunotherapy in relapsed or refractory lymphoma
por: Zhou, Jin, et al.
Publicado: (2022)

Bee venom and SARS-CoV-2
por: Yang, Wei, et al.
Publicado: (2020)

Cosmetic Applications of Bee Venom
por: El-Wahed, Aida A. Abd, et al.
Publicado: (2021)

Fatty tumors of the retroperitoneum: Lipoma or well-differentiated liposarcoma. About a case of a giant retroperitoneal liposarcoma
por: bibi, Mokhtar, et al.
Publicado: (2018)

Afatinib combined with anti-PD1 enhances immunotherapy of hepatocellular carcinoma via ERBB2/STAT3/PD-L1 signaling
por: Yu, Chao, et al.
Publicado: (2023)

Immunotherapy in Ovarian Cancer: Thinking Beyond PD-1/PD-L1
por: Chardin, Laure, et al.
Publicado: (2021)

A phase II study of buparlisib in relapsed or refractory thymomas
por: Abu Zaid, Mohammad I., et al.
Publicado: (2022)

Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma
por: Wieczorek, Aleksandra, et al.
Publicado: (2023)

The Role of PD-L1 Expression in Prediction and Stratification of Recurrent or Refractory Extranodal Natural Killer/T-Cell Lymphoma
por: Gao, Li-Min, et al.
Publicado: (2022)

Anti-Tumor Effect of Apatinib and Relevant Mechanisms in Liposarcoma
por: Cui, Lixuan, et al.
Publicado: (2021)

Case Report: Outcome and Adverse Events of Anti-PD-1 Antibody Plus Chidamide for Relapsed/Refractory Sézary Syndrome: Case Series and A Literature Review
por: Chen, Chao, et al.
Publicado: (2022)

Relapsed/refractory diffuse large B cell lymphoma with cardiac involvement: A case report and literature review
por: Yang, Yuanyuan, et al.
Publicado: (2023)

About a case of paratesticular myxoid liposarcoma
por: Ayari, Yassine, et al.
Publicado: (2018)

A rare case of liposarcoma of the spermatic cord
por: Dunev, V.R., et al.
Publicado: (2020)

Primary myxoid liposarcoma of the pelvis: An unusual location
por: Rico Gala, Susana, et al.
Publicado: (2020)

Bee Venom in Wound Healing
por: Kurek-Górecka, Anna, et al.
Publicado: (2020)

Novel Agents For Relapsed and Refractory Classical Hodgkin Lymphoma: A Review
por: Zhang, Yujie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3tb9u7n8mad62bpefhjo6eu5in